Events

Recall of angiographic catheter imager ii

According to Health Andorra, this recall involved a device in Andorra that was produced by Boston Scientific.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    ARS/2016/11812
  • Date
    2016-12-27
  • Event Country
    Andorra
  • Event Source
    HA
  • Event Source URL
    https://www.salut.ad/alertes/alertes.php?_pagi_pg=44&data1=&data2=&tipus=PRODUCTES%20SANITARIS%20-%20Retirada&titol=
  • Notes / Alerts
    Data from Andorra is current through November 2018. All of the data comes from Health Andorra, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Andorra.
  • Extra notes in the data

Device

angiographic catheter imager ii
  • Model / Serial
  • Product Description
    Catheter alert angiography imager ii-boston
  • Manufacturer
    Boston Scientific

Manufacturer

Boston Scientific
  • Manufacturer Parent Company (2017)
    Boston Scientific
  • Manufacturer comment
    “We take a patient-first approach to assessing the applicability of every recall and communicate to regulatory bodies in all geographies where the recalled device is sold,” Boston Scientific said in a statement to ICIJ. “We have coordinated several recalls across many countries in a timely manner,” the company said, adding that it complies with all national laws, which can often vary and require different processes for reporting information or taking action on recalls. The company said it uses a rigorous and uniform process to take action on recalls and that “when we initiate a field action (e.g. recall, safety alert), every customer who has received an affected product receives a communication that includes a letter for the physician.”
  • Source
    HA